Veeva Systems to Showcase AI Innovations at Upcoming R&D and Quality Summit

Veeva Systems Inc (VEEV) is set to host its R&D and Quality Summit on September 3-4, 2025, in Boston. The event will feature over 100 sessions and showcase the company's latest innovations, including AI technology integrated into its Vault Platform. The summit will bring together industry leaders from major biopharmaceutical companies such as Merck, Pfizer, and Sanofi. The event highlights Veeva's commitment to innovation and customer success, but investors should be cautious of the forward-looking statements and inherent risks associated with new technology implementations.

Veeva Systems Inc. (VEEV) is set to host its R&D and Quality Summit on September 3-4, 2025, in Boston. The event will feature over 100 sessions and showcase the company's latest innovations, including AI technology integrated into its Vault Platform. The summit will bring together industry leaders from major biopharmaceutical companies such as Merck, Pfizer, and Sanofi.

The summit will highlight Veeva's commitment to innovation and customer success. BeOne Medicines, Intercept Pharmaceuticals, Merck, and Pfizer are among the leaders coming together to share their strategies for advancing clinical, regulatory, safety, and quality [1]. Veeva will showcase advancements in software, data, and business consulting, including Veeva AI. The AI for life sciences, Veeva AI, is built into the Vault Platform with direct and secure access to Vault data, documents, and workflows. Customers will learn more about the deep Veeva AI Agents being delivered for Veeva applications and how they can use Veeva AI to create their own custom agents [1].

The summit will also feature presentations on accelerating development and manufacturing by connecting systems and processes. Merck streamlines clinical operations with unified operations and data management and standardizes data cross-functionally with a single pharmacovigilance platform. FUJIFILM Biotechnologies moves from a site-based approach to a global quality management system to drive consistency for greater visibility and control. BeOne Medicine modernizes regulatory processes, increasing efficiency and strengthening compliance with multi-health authority submissions. Immunovant improves study oversight in outsourced trials with real-time access to CRO data to save time and prevent errors. Sanofi streamlines study training with a single, inspection-ready solution, eliminating disconnected systems across study teams and site staff. Memorial Sloan Kettering Cancer Center (MSK) improves engagement with sponsors and CROs and shares a site perspective [1].

Veeva's commitment to innovation extends to its Quality Cloud, which is now recognized as one of four core businesses at the company. The company is investing in practical enhancements to its QualityDocs application and gaining traction with newer offerings such as Veeva Validation Management, Batch Release, and LIMS. Veeva is also expanding its product roadmap to include Environmental Health and Safety (EHS) and Supplier Surveillance, driven by customer feedback and the need for industry collaboration [2].

While the summit promises to be a significant event for the life sciences industry, investors should be cautious of the forward-looking statements and inherent risks associated with new technology implementations. Veeva's forward-looking statements are based on current expectations and actual results could differ materially from those provided in this release. There are numerous risks that could negatively impact Veeva's results, including those disclosed in its Form 10-Q for the period ended April 30, 2025 [1].

References:
[1] https://www.prnewswire.com/news-releases/leaders-come-together-to-advance-the-industry-at-veeva-summit-302535201.html
[2] https://axendia.com/blog/2025/08/20/veeva-expands-its-vision-for-quality-and-manufacturing/